Trials / Completed
CompletedNCT01660815
A Study of Florbetapir (18F) in Japanese Healthy Volunteers
PET Whole Body Biodistribution Using Florbetapir (18F)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Avid Radiopharmaceuticals · Industry
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Accepted
Summary
This study will determine how florbetapir (18F) (18F-AV-45) radioactivity is distributed throughout the body of Japanese subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | florbetapir (18F) | IV injection, 370 MBq (10mCi), single dose |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2012-08-09
- Last updated
- 2013-09-19
- Results posted
- 2013-09-19
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01660815. Inclusion in this directory is not an endorsement.